{"schemaVersion":1,"title":"Becton Dickinson & Co Revenue","path":"/stock/bdx/revenue","topic":"revenue","company":{"symbol":"bdx","name":"Becton Dickinson & Co","exchange":"NYSE","currency":"USD","aliases":[]},"retrievedAt":"2026-09-28T18:23:16.063Z","periodBasis":"fiscal","options":{"range":"5Y","deductSbc":false,"limit":200,"offset":0,"frequency":"quarterly","wacc":7.7},"definitions":[{"id":"total_revenue","label":"Total revenue","unit":"USD_millions","formula":"Reported consolidated revenue from the issuer filing. Each observation identifies its accounting concept; bank net revenue is net of interest expense when that concept is reported."}],"latest":{"period":"2026-Q3","end":"2026-06-30","start":"2026-04-01","values":{"total_revenue":4983},"issues":{},"observations":{"total_revenue":{"value":4983,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-26-000035","form":"10-Q","filed":"2026-08-06","start":"2026-04-01","end":"2026-06-30","rawValue":4983000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079526000035/0000010795-26-000035-index.html"}],"issue":null}}},"rows":[{"period":"2026-Q3","end":"2026-06-30","start":"2026-04-01","values":{"total_revenue":4983},"issues":{},"observations":{"total_revenue":{"value":4983,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-26-000035","form":"10-Q","filed":"2026-08-06","start":"2026-04-01","end":"2026-06-30","rawValue":4983000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079526000035/0000010795-26-000035-index.html"}],"issue":null}}},{"period":"2026-Q2","end":"2026-03-31","start":"2026-01-01","values":{"total_revenue":4714},"issues":{},"observations":{"total_revenue":{"value":4714,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-26-000026","form":"10-Q","filed":"2026-05-07","start":"2026-01-01","end":"2026-03-31","rawValue":4714000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079526000026/0000010795-26-000026-index.html"}],"issue":null}}},{"period":"2026-Q1","end":"2025-12-31","start":"2025-10-01","values":{"total_revenue":5252},"issues":{},"observations":{"total_revenue":{"value":5252,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-26-000005","form":"10-Q","filed":"2026-02-09","start":"2025-10-01","end":"2025-12-31","rawValue":5252000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079526000005/0000010795-26-000005-index.html"}],"issue":null}}},{"period":"2025-Q4","end":"2025-09-30","start":"2025-07-01","values":{"total_revenue":5891},"issues":{},"observations":{"total_revenue":{"value":5891,"method":"difference","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-25-000099","form":"10-K","filed":"2025-11-25","start":"2024-10-01","end":"2025-09-30","rawValue":21840000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079525000099/0000010795-25-000099-index.html"},{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-25-000072","form":"10-Q","filed":"2025-08-07","start":"2024-10-01","end":"2025-06-30","rawValue":15949000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079525000072/0000010795-25-000072-index.html"}],"issue":null}}},{"period":"2025-Q3","end":"2025-06-30","start":"2025-04-01","values":{"total_revenue":5509},"issues":{},"observations":{"total_revenue":{"value":5509,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-25-000072","form":"10-Q","filed":"2025-08-07","start":"2025-04-01","end":"2025-06-30","rawValue":5509000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079525000072/0000010795-25-000072-index.html"}],"issue":null}}},{"period":"2025-Q2","end":"2025-03-31","start":"2025-01-01","values":{"total_revenue":5272},"issues":{},"observations":{"total_revenue":{"value":5272,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-25-000039","form":"10-Q","filed":"2025-05-01","start":"2025-01-01","end":"2025-03-31","rawValue":5272000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079525000039/0000010795-25-000039-index.html"}],"issue":null}}},{"period":"2025-Q1","end":"2024-12-31","start":"2024-10-01","values":{"total_revenue":5168},"issues":{},"observations":{"total_revenue":{"value":5168,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-25-000022","form":"10-Q","filed":"2025-02-06","start":"2024-10-01","end":"2024-12-31","rawValue":5168000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079525000022/0000010795-25-000022-index.html"}],"issue":null}}},{"period":"2024-Q4","end":"2024-09-30","start":"2024-07-01","values":{"total_revenue":5437},"issues":{},"observations":{"total_revenue":{"value":5437,"method":"difference","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-24-000084","form":"10-K","filed":"2024-11-27","start":"2023-10-01","end":"2024-09-30","rawValue":20178000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079524000084/0000010795-24-000084-index.html"},{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-24-000067","form":"10-Q","filed":"2024-08-01","start":"2023-10-01","end":"2024-06-30","rawValue":14741000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079524000067/0000010795-24-000067-index.html"}],"issue":null}}},{"period":"2024-Q3","end":"2024-06-30","start":"2024-04-01","values":{"total_revenue":4990},"issues":{},"observations":{"total_revenue":{"value":4990,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-24-000067","form":"10-Q","filed":"2024-08-01","start":"2024-04-01","end":"2024-06-30","rawValue":4990000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079524000067/0000010795-24-000067-index.html"}],"issue":null}}},{"period":"2024-Q2","end":"2024-03-31","start":"2024-01-01","values":{"total_revenue":5045},"issues":{},"observations":{"total_revenue":{"value":5045,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-24-000039","form":"10-Q","filed":"2024-05-02","start":"2024-01-01","end":"2024-03-31","rawValue":5045000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079524000039/0000010795-24-000039-index.html"}],"issue":null}}},{"period":"2024-Q1","end":"2023-12-31","start":"2023-10-01","values":{"total_revenue":4706},"issues":{},"observations":{"total_revenue":{"value":4706,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-24-000019","form":"10-Q","filed":"2024-02-01","start":"2023-10-01","end":"2023-12-31","rawValue":4706000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079524000019/0000010795-24-000019-index.html"}],"issue":null}}},{"period":"2023-Q4","end":"2023-09-30","start":"2023-07-01","values":{"total_revenue":5087},"issues":{},"observations":{"total_revenue":{"value":5087,"method":"difference","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-23-000098","form":"10-K","filed":"2023-11-21","start":"2022-10-01","end":"2023-09-30","rawValue":19372000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079523000098/0000010795-23-000098-index.html"},{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-23-000075","form":"10-Q","filed":"2023-08-03","start":"2022-10-01","end":"2023-06-30","rawValue":14285000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079523000075/0000010795-23-000075-index.html"}],"issue":null}}},{"period":"2023-Q3","end":"2023-06-30","start":"2023-04-01","values":{"total_revenue":4878},"issues":{},"observations":{"total_revenue":{"value":4878,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-23-000075","form":"10-Q","filed":"2023-08-03","start":"2023-04-01","end":"2023-06-30","rawValue":4878000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079523000075/0000010795-23-000075-index.html"}],"issue":null}}},{"period":"2023-Q2","end":"2023-03-31","start":"2023-01-01","values":{"total_revenue":4821},"issues":{},"observations":{"total_revenue":{"value":4821,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-23-000039","form":"10-Q","filed":"2023-05-04","start":"2023-01-01","end":"2023-03-31","rawValue":4821000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079523000039/0000010795-23-000039-index.html"}],"issue":null}}},{"period":"2023-Q1","end":"2022-12-31","start":"2022-10-01","values":{"total_revenue":4586},"issues":{},"observations":{"total_revenue":{"value":4586,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-23-000030","form":"10-Q","filed":"2023-02-02","start":"2022-10-01","end":"2022-12-31","rawValue":4586000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079523000030/0000010795-23-000030-index.html"}],"issue":null}}},{"period":"2022-Q4","end":"2022-09-30","start":"2022-07-01","values":{"total_revenue":4761},"issues":{},"observations":{"total_revenue":{"value":4761,"method":"difference","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0001628280-22-030686","form":"10-K","filed":"2022-11-22","start":"2021-10-01","end":"2022-09-30","rawValue":18870000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000162828022030686/0001628280-22-030686-index.html"},{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-22-000052","form":"10-Q","filed":"2022-08-04","start":"2021-10-01","end":"2022-06-30","rawValue":14109000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079522000052/0000010795-22-000052-index.html"}],"issue":null}}},{"period":"2022-Q3","end":"2022-06-30","start":"2022-04-01","values":{"total_revenue":4641},"issues":{},"observations":{"total_revenue":{"value":4641,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-22-000052","form":"10-Q","filed":"2022-08-04","start":"2022-04-01","end":"2022-06-30","rawValue":4641000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079522000052/0000010795-22-000052-index.html"}],"issue":null}}},{"period":"2022-Q2","end":"2022-03-31","start":"2022-01-01","values":{"total_revenue":5011},"issues":{},"observations":{"total_revenue":{"value":5011,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-22-000040","form":"10-Q","filed":"2022-05-05","start":"2022-01-01","end":"2022-03-31","rawValue":5011000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079522000040/0000010795-22-000040-index.html"}],"issue":null}}},{"period":"2022-Q1","end":"2021-12-31","start":"2021-10-01","values":{"total_revenue":4995},"issues":{},"observations":{"total_revenue":{"value":4995,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-22-000017","form":"10-Q","filed":"2022-02-03","start":"2021-10-01","end":"2021-12-31","rawValue":4995000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079522000017/0000010795-22-000017-index.html"}],"issue":null}}},{"period":"2021-Q4","end":"2021-09-30","start":"2021-07-01","values":{"total_revenue":5135},"issues":{},"observations":{"total_revenue":{"value":5135,"method":"difference","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-21-000091","form":"10-K","filed":"2021-11-24","start":"2020-10-01","end":"2021-09-30","rawValue":20248000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079521000091/0000010795-21-000091-index.html"},{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-21-000057","form":"10-Q","filed":"2021-08-05","start":"2020-10-01","end":"2021-06-30","rawValue":15113000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079521000057/0000010795-21-000057-index.html"}],"issue":null}}},{"period":"2021-Q3","end":"2021-06-30","start":"2021-04-01","values":{"total_revenue":4890},"issues":{},"observations":{"total_revenue":{"value":4890,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-21-000057","form":"10-Q","filed":"2021-08-05","start":"2021-04-01","end":"2021-06-30","rawValue":4890000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079521000057/0000010795-21-000057-index.html"}],"issue":null}}},{"period":"2021-Q2","end":"2021-03-31","start":"2021-01-01","values":{"total_revenue":4907},"issues":{},"observations":{"total_revenue":{"value":4907,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-21-000046","form":"10-Q","filed":"2021-05-06","start":"2021-01-01","end":"2021-03-31","rawValue":4907000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079521000046/0000010795-21-000046-index.html"}],"issue":null}}},{"period":"2021-Q1","end":"2020-12-31","start":"2020-10-01","values":{"total_revenue":5315},"issues":{},"observations":{"total_revenue":{"value":5315,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-21-000029","form":"10-Q","filed":"2021-02-04","start":"2020-10-01","end":"2020-12-31","rawValue":5315000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079521000029/0000010795-21-000029-index.html"}],"issue":null}}},{"period":"2020-Q4","end":"2020-09-30","start":"2020-07-01","values":{"total_revenue":4784},"issues":{},"observations":{"total_revenue":{"value":4784,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-20-000055","form":"10-K","filed":"2020-11-25","start":"2020-07-01","end":"2020-09-30","rawValue":4784000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079520000055/0000010795-20-000055-index.html"}],"issue":null}}},{"period":"2020-Q3","end":"2020-06-30","start":"2020-04-01","values":{"total_revenue":3855},"issues":{},"observations":{"total_revenue":{"value":3855,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-20-000027","form":"10-Q","filed":"2020-08-06","start":"2020-04-01","end":"2020-06-30","rawValue":3855000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079520000027/0000010795-20-000027-index.html"}],"issue":null}}},{"period":"2020-Q2","end":"2020-03-31","start":"2020-01-01","values":{"total_revenue":4253},"issues":{},"observations":{"total_revenue":{"value":4253,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-20-000019","form":"10-Q","filed":"2020-05-07","start":"2020-01-01","end":"2020-03-31","rawValue":4253000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079520000019/0000010795-20-000019-index.html"}],"issue":null}}},{"period":"2020-Q1","end":"2019-12-31","start":"2019-10-01","values":{"total_revenue":4225},"issues":{},"observations":{"total_revenue":{"value":4225,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-20-000010","form":"10-Q","filed":"2020-02-06","start":"2019-10-01","end":"2019-12-31","rawValue":4225000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079520000010/0000010795-20-000010-index.html"}],"issue":null}}},{"period":"2019-Q4","end":"2019-09-30","start":"2019-07-01","values":{"total_revenue":4584},"issues":{},"observations":{"total_revenue":{"value":4584,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-19-000044","form":"10-K","filed":"2019-11-27","start":"2019-07-01","end":"2019-09-30","rawValue":4584000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079519000044/0000010795-19-000044-index.html"}],"issue":null}}},{"period":"2019-Q3","end":"2019-06-30","start":"2019-04-01","values":{"total_revenue":4350},"issues":{},"observations":{"total_revenue":{"value":4350,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-19-000031","form":"10-Q","filed":"2019-08-06","start":"2019-04-01","end":"2019-06-30","rawValue":4350000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079519000031/0000010795-19-000031-index.html"}],"issue":null}}},{"period":"2019-Q2","end":"2019-03-31","start":"2019-01-01","values":{"total_revenue":4195},"issues":{},"observations":{"total_revenue":{"value":4195,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-19-000022","form":"10-Q","filed":"2019-05-09","start":"2019-01-01","end":"2019-03-31","rawValue":4195000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079519000022/0000010795-19-000022-index.html"}],"issue":null}}},{"period":"2019-Q1","end":"2018-12-31","start":"2018-10-01","values":{"total_revenue":4160},"issues":{},"observations":{"total_revenue":{"value":4160,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-19-000009","form":"10-Q","filed":"2019-02-05","start":"2018-10-01","end":"2018-12-31","rawValue":4160000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079519000009/0000010795-19-000009-index.html"}],"issue":null}}},{"period":"2018-Q4","end":"2018-09-30","start":"2018-07-01","values":{"total_revenue":4402},"issues":{},"observations":{"total_revenue":{"value":4402,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-18-000036","form":"10-K","filed":"2018-11-21","start":"2018-07-01","end":"2018-09-30","rawValue":4402000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079518000036/0000010795-18-000036-index.html"}],"issue":null}}},{"period":"2018-Q3","end":"2018-06-30","start":"2018-04-01","values":{"total_revenue":4278},"issues":{},"observations":{"total_revenue":{"value":4278,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:Revenues","accession":"0000010795-18-000023","form":"10-Q","filed":"2018-08-02","start":"2018-04-01","end":"2018-06-30","rawValue":4278000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079518000023/0000010795-18-000023-index.html"}],"issue":null}}},{"period":"2018-Q2","end":"2018-03-31","start":"2018-01-01","values":{"total_revenue":4222},"issues":{},"observations":{"total_revenue":{"value":4222,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0000010795-18-000018","form":"10-Q","filed":"2018-05-03","start":"2018-01-01","end":"2018-03-31","rawValue":4222000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079518000018/0000010795-18-000018-index.html"}],"issue":null}}},{"period":"2018-Q1","end":"2017-12-31","start":"2017-10-01","values":{"total_revenue":3080},"issues":{},"observations":{"total_revenue":{"value":3080,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0000010795-18-000008","form":"10-Q","filed":"2018-02-06","start":"2017-10-01","end":"2017-12-31","rawValue":3080000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079518000008/0000010795-18-000008-index.html"}],"issue":null}}},{"period":"2017-Q4","end":"2017-09-30","start":"2017-07-01","values":{"total_revenue":3166},"issues":{},"observations":{"total_revenue":{"value":3166,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0000010795-17-000021","form":"10-K","filed":"2017-11-22","start":"2017-07-01","end":"2017-09-30","rawValue":3166000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079517000021/0000010795-17-000021-index.html"}],"issue":null}}},{"period":"2017-Q3","end":"2017-06-30","start":"2017-04-01","values":{"total_revenue":3035},"issues":{},"observations":{"total_revenue":{"value":3035,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0000010795-17-000012","form":"10-Q","filed":"2017-08-03","start":"2017-04-01","end":"2017-06-30","rawValue":3035000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079517000012/0000010795-17-000012-index.html"}],"issue":null}}},{"period":"2017-Q2","end":"2017-03-31","start":"2017-01-01","values":{"total_revenue":2969},"issues":{},"observations":{"total_revenue":{"value":2969,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0000010795-17-000008","form":"10-Q","filed":"2017-05-02","start":"2017-01-01","end":"2017-03-31","rawValue":2969000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079517000008/0000010795-17-000008-index.html"}],"issue":null}}},{"period":"2017-Q1","end":"2016-12-31","start":"2016-10-01","values":{"total_revenue":2922},"issues":{},"observations":{"total_revenue":{"value":2922,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0000010795-17-000002","form":"10-Q","filed":"2017-02-02","start":"2016-10-01","end":"2016-12-31","rawValue":2922000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079517000002/0000010795-17-000002-index.html"}],"issue":null}}},{"period":"2016-Q4","end":"2016-09-30","start":"2016-07-01","values":{"total_revenue":3231},"issues":{},"observations":{"total_revenue":{"value":3231,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001628280-16-021658","form":"10-K","filed":"2016-11-23","start":"2016-07-01","end":"2016-09-30","rawValue":3231000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000162828016021658/0001628280-16-021658-index.html"}],"issue":null}}},{"period":"2016-Q3","end":"2016-06-30","start":"2016-04-01","values":{"total_revenue":3198},"issues":{},"observations":{"total_revenue":{"value":3198,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001628280-16-018452","form":"10-Q","filed":"2016-08-04","start":"2016-04-01","end":"2016-06-30","rawValue":3198000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000162828016018452/0001628280-16-018452-index.html"}],"issue":null}}},{"period":"2016-Q2","end":"2016-03-31","start":"2016-01-01","values":{"total_revenue":3067},"issues":{},"observations":{"total_revenue":{"value":3067,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001628280-16-015791","form":"10-Q","filed":"2016-05-06","start":"2016-01-01","end":"2016-03-31","rawValue":3067000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000162828016015791/0001628280-16-015791-index.html"}],"issue":null}}},{"period":"2016-Q1","end":"2015-12-31","start":"2015-10-01","values":{"total_revenue":2986},"issues":{},"observations":{"total_revenue":{"value":2986,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001628280-16-010787","form":"10-Q","filed":"2016-02-05","start":"2015-10-01","end":"2015-12-31","rawValue":2986000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000162828016010787/0001628280-16-010787-index.html"}],"issue":null}}},{"period":"2015-Q4","end":"2015-09-30","start":"2015-07-01","values":{"total_revenue":3059},"issues":{},"observations":{"total_revenue":{"value":3059,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001628280-15-008984","form":"10-K","filed":"2015-11-25","start":"2015-07-01","end":"2015-09-30","rawValue":3059000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000162828015008984/0001628280-15-008984-index.html"}],"issue":null}}},{"period":"2015-Q3","end":"2015-06-30","start":"2015-04-01","values":{"total_revenue":3120},"issues":{},"observations":{"total_revenue":{"value":3120,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001193125-15-280441","form":"10-Q","filed":"2015-08-06","start":"2015-04-01","end":"2015-06-30","rawValue":3120000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000119312515280441/0001193125-15-280441-index.html"}],"issue":null}}},{"period":"2015-Q2","end":"2015-03-31","start":"2015-01-01","values":{"total_revenue":2051},"issues":{},"observations":{"total_revenue":{"value":2051,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001193125-15-178817","form":"10-Q","filed":"2015-05-08","start":"2015-01-01","end":"2015-03-31","rawValue":2051000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000119312515178817/0001193125-15-178817-index.html"}],"issue":null}}},{"period":"2015-Q1","end":"2014-12-31","start":"2014-10-01","values":{"total_revenue":2051},"issues":{},"observations":{"total_revenue":{"value":2051,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001193125-15-037325","form":"10-Q","filed":"2015-02-06","start":"2014-10-01","end":"2014-12-31","rawValue":2051000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000119312515037325/0001193125-15-037325-index.html"}],"issue":null}}},{"period":"2014-Q4","end":"2014-09-30","start":"2014-07-01","values":{"total_revenue":2202},"issues":{},"observations":{"total_revenue":{"value":2202,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001628280-15-008984","form":"10-K","filed":"2015-11-25","start":"2014-07-01","end":"2014-09-30","rawValue":2202000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000162828015008984/0001628280-15-008984-index.html"}],"issue":null}}},{"period":"2014-Q3","end":"2014-06-30","start":"2014-04-01","values":{"total_revenue":2157},"issues":{},"observations":{"total_revenue":{"value":2157,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001193125-14-292835","form":"10-Q","filed":"2014-08-04","start":"2014-04-01","end":"2014-06-30","rawValue":2157000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000119312514292835/0001193125-14-292835-index.html"}],"issue":null}}},{"period":"2014-Q2","end":"2014-03-31","start":"2014-01-01","values":{"total_revenue":2072},"issues":{},"observations":{"total_revenue":{"value":2072,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001193125-14-182198","form":"10-Q","filed":"2014-05-05","start":"2014-01-01","end":"2014-03-31","rawValue":2072000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000119312514182198/0001193125-14-182198-index.html"}],"issue":null}}},{"period":"2014-Q1","end":"2013-12-31","start":"2013-10-01","values":{"total_revenue":2015},"issues":{},"observations":{"total_revenue":{"value":2015,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001193125-14-042815","form":"10-Q","filed":"2014-02-10","start":"2013-10-01","end":"2013-12-31","rawValue":2015000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000119312514042815/0001193125-14-042815-index.html"}],"issue":null}}},{"period":"2013-Q4","end":"2013-09-30","start":"2013-07-01","values":{"total_revenue":2100.768},"issues":{},"observations":{"total_revenue":{"value":2100.768,"method":"difference","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001193125-13-456802","form":"10-K","filed":"2013-11-27","start":"2012-10-01","end":"2013-09-30","rawValue":8054000000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000119312513456802/0001193125-13-456802-index.html"},{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001193125-13-318898","form":"10-Q","filed":"2013-08-05","start":"2012-10-01","end":"2013-06-30","rawValue":5953232000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000119312513318898/0001193125-13-318898-index.html"}],"issue":null}}},{"period":"2013-Q3","end":"2013-06-30","start":"2013-04-01","values":{"total_revenue":2052.664},"issues":{},"observations":{"total_revenue":{"value":2052.664,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001193125-13-318898","form":"10-Q","filed":"2013-08-05","start":"2013-04-01","end":"2013-06-30","rawValue":2052664000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000119312513318898/0001193125-13-318898-index.html"}],"issue":null}}},{"period":"2013-Q2","end":"2013-03-31","start":"2012-12-25","values":{"total_revenue":2000.375},"issues":{},"observations":{"total_revenue":{"value":2000.375,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001193125-13-210262","form":"10-Q","filed":"2013-05-09","start":"2012-12-25","end":"2013-03-31","rawValue":2000375000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000119312513210262/0001193125-13-210262-index.html"}],"issue":null}}},{"period":"2013-Q1","end":"2012-12-31","start":"2012-10-01","values":{"total_revenue":1900.192},"issues":{},"observations":{"total_revenue":{"value":1900.192,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001193125-13-043243","form":"10-Q","filed":"2013-02-07","start":"2012-10-01","end":"2012-12-31","rawValue":1900192000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000119312513043243/0001193125-13-043243-index.html"}],"issue":null}}},{"period":"2012-Q4","end":"2012-09-30","start":"2012-07-01","values":{"total_revenue":1967.171},"issues":{},"observations":{"total_revenue":{"value":1967.171,"method":"difference","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001193125-12-478705","form":"10-K","filed":"2012-11-21","start":"2011-10-01","end":"2012-09-30","rawValue":7708382000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000119312512478705/0001193125-12-478705-index.html"},{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001193125-12-337327","form":"10-Q","filed":"2012-08-06","start":"2011-10-01","end":"2012-06-30","rawValue":5741211000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000119312512337327/0001193125-12-337327-index.html"}],"issue":null}}},{"period":"2012-Q3","end":"2012-06-30","start":"2012-04-01","values":{"total_revenue":1980.53},"issues":{},"observations":{"total_revenue":{"value":1980.53,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001193125-12-337327","form":"10-Q","filed":"2012-08-06","start":"2012-04-01","end":"2012-06-30","rawValue":1980530000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000119312512337327/0001193125-12-337327-index.html"}],"issue":null}}},{"period":"2012-Q2","end":"2012-03-31","start":"2012-01-01","values":{"total_revenue":1990.818},"issues":{},"observations":{"total_revenue":{"value":1990.818,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001193125-12-207740","form":"10-Q","filed":"2012-05-03","start":"2012-01-01","end":"2012-03-31","rawValue":1990818000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000119312512207740/0001193125-12-207740-index.html"}],"issue":null}}},{"period":"2012-Q1","end":"2011-12-31","start":"2011-10-01","values":{"total_revenue":1887.645},"issues":{},"observations":{"total_revenue":{"value":1887.645,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0001193125-12-043140","form":"10-Q","filed":"2012-02-07","start":"2011-10-01","end":"2011-12-31","rawValue":1887645000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000119312512043140/0001193125-12-043140-index.html"}],"issue":null}}},{"period":"2011-Q4","end":"2011-09-30","start":"2011-07-01","values":{"total_revenue":2050.795},"issues":{},"observations":{"total_revenue":{"value":2050.795,"method":"difference","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0000950123-11-100266","form":"10-K","filed":"2011-11-23","start":"2010-10-01","end":"2011-09-30","rawValue":7828904000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000095012311100266/0000950123-11-100266-index.html"},{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0000950123-11-071624","form":"10-Q","filed":"2011-08-02","start":"2010-10-01","end":"2011-06-30","rawValue":5778109000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000095012311071624/0000950123-11-071624-index.html"}],"issue":null}}},{"period":"2011-Q3","end":"2011-06-30","start":"2011-04-01","values":{"total_revenue":2014.081},"issues":{},"observations":{"total_revenue":{"value":2014.081,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0000950123-11-071624","form":"10-Q","filed":"2011-08-02","start":"2011-04-01","end":"2011-06-30","rawValue":2014081000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000095012311071624/0000950123-11-071624-index.html"}],"issue":null}}},{"period":"2011-Q2","end":"2011-03-31","start":"2011-01-01","values":{"total_revenue":1922.023},"issues":{},"observations":{"total_revenue":{"value":1922.023,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0000950123-11-044344","form":"10-Q","filed":"2011-05-04","start":"2011-01-01","end":"2011-03-31","rawValue":1922023000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000095012311044344/0000950123-11-044344-index.html"}],"issue":null}}},{"period":"2011-Q1","end":"2010-12-31","start":"2010-10-01","values":{"total_revenue":1842.005},"issues":{},"observations":{"total_revenue":{"value":1842.005,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0000950123-11-010361","form":"10-Q","filed":"2011-02-08","start":"2010-10-01","end":"2010-12-31","rawValue":1842005000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000095012311010361/0000950123-11-010361-index.html"}],"issue":null}}},{"period":"2010-Q4","end":"2010-09-30","start":"2010-07-01","values":{"total_revenue":1732.476},"issues":{},"observations":{"total_revenue":{"value":1732.476,"method":"difference","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0000950123-10-108757","form":"10-K","filed":"2010-11-24","start":"2009-10-01","end":"2010-09-30","rawValue":7372333000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000095012310108757/0000950123-10-108757-index.html"},{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0000950123-10-072399","form":"10-Q","filed":"2010-08-04","start":"2009-10-01","end":"2010-06-30","rawValue":5639857000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000095012310072399/0000950123-10-072399-index.html"}],"issue":null}}},{"period":"2010-Q3","end":"2010-06-30","start":"2010-04-01","values":{"total_revenue":1878.229},"issues":{},"observations":{"total_revenue":{"value":1878.229,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0000950123-10-072399","form":"10-Q","filed":"2010-08-04","start":"2010-04-01","end":"2010-06-30","rawValue":1878229000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000095012310072399/0000950123-10-072399-index.html"}],"issue":null}}},{"period":"2010-Q2","end":"2010-03-31","start":"2010-01-01","values":{"total_revenue":1844.854},"issues":{},"observations":{"total_revenue":{"value":1844.854,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0000950123-10-045358","form":"10-Q","filed":"2010-05-06","start":"2010-01-01","end":"2010-03-31","rawValue":1844854000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000095012310045358/0000950123-10-045358-index.html"}],"issue":null}}},{"period":"2010-Q1","end":"2009-12-31","start":"2009-10-01","values":{"total_revenue":1916.774},"issues":{},"observations":{"total_revenue":{"value":1916.774,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0000950123-10-009988","form":"10-Q","filed":"2010-02-08","start":"2009-10-01","end":"2009-12-31","rawValue":1916774000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000095012310009988/0000950123-10-009988-index.html"}],"issue":null}}},{"period":"2009-Q4","end":"2009-09-30","start":"2009-07-01","values":{"total_revenue":1897.733},"issues":{},"observations":{"total_revenue":{"value":1897.733,"method":"difference","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0000950123-10-004150","form":"10-K/A","filed":"2010-01-21","start":"2008-10-01","end":"2009-09-30","rawValue":7160874000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000095012310004150/0000950123-10-004150-index.html"},{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0000950123-09-032660","form":"10-Q","filed":"2009-08-10","start":"2008-10-01","end":"2009-06-30","rawValue":5263141000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000095012309032660/0000950123-09-032660-index.html"}],"issue":null}}},{"period":"2009-Q3","end":"2009-06-30","start":"2009-04-01","values":{"total_revenue":1820.255},"issues":{},"observations":{"total_revenue":{"value":1820.255,"method":"reported","evidence":[{"sourceId":"sec-0000010795-2412ff584fd7","tag":"us-gaap:SalesRevenueNet","accession":"0000950123-09-032660","form":"10-Q","filed":"2009-08-10","start":"2009-04-01","end":"2009-06-30","rawValue":1820255000,"unit":"USD","url":"https://www.sec.gov/Archives/edgar/data/10795/000095012309032660/0000950123-09-032660-index.html"}],"issue":null}}}],"pagination":{"total":69,"limit":200,"offset":0,"order":"newest_first","nextOffset":null},"coverage":{"from":"2009-06-30","through":"2026-06-30","dailyValuation":false},"sources":[{"url":"https://data.sec.gov/api/xbrl/companyfacts/CIK0000010795.json","retrievedAt":"2026-09-28T07:37:41.538Z","sha256":"2412ff584fd74aa61f919bc5813a0bb523fdf03f20d6104f3167cc19c3ba84b9","cik":"0000010795","id":"sec-0000010795-2412ff584fd7"}],"pendingFiling":null,"market":{"currency":"USD","url":"https://query1.finance.yahoo.com/v8/finance/chart/BDX?interval=1d&period1=946684800&period2=1793160965&events=splits","source":"Yahoo Finance","retrievedAt":"2026-10-28T04:16:05.959Z","sha256":"abf1f246a9d2bfd4c05552a42db1d61ab81adf606872709ffc79c33aa38ff6ab","latest":{"date":"2026-10-27","close":195.02999877929688}},"rawDataPath":"/api/v2/financials/bdx","notes":["Null means an unavailable input or undefined calculation, never zero. Values are unrounded; money and shares are in millions unless a column states otherwise.","Fiscal periods use actual reporting start/end dates. Annual reported values are not constructed by adding quarterly EPS or weighted share counts. Partial years are labelled.","FCF uses operating cash flow minus reported cash capital investment, preferring PPE purchases. The productive-assets fallback can also include software and intangibles. Acquisitions and noncash leases are excluded. Deduct SBC is an optional economic-cost scenario; missing SBC remains unavailable.","SBC / FCF and SBC / OCF compare amounts from the same fiscal period. SBC / FCF always uses FCF before SBC deduction; nonpositive denominators are undefined and values above 100% remain valid.","Capital allocation percentages describe available tracked cash uses, not all company spending or a fraction of OCF. Missing categories remain null, negative payments are excluded and SBC is noncash. Annual shares use reported annual amounts.","Valuation uses completed, split-adjusted closes without dividend adjustment and a complete trailing year. Financial bases become eligible after publication; selected facts can contain later restatements. This is not a vintage-filings backtest.","Mean and median use all valid observations in the selected date range before pagination. Historical pricing labels compare the latest positive value with its own median and do not estimate intrinsic fair value.","Reporting currencies are retained without conversion. USD market capitalization, where available, is a separate dated Nasdaq snapshot.","WACC is an editable US industry scenario across history, not a historical company cost of capital. Industry exclusions, missing inputs and pending filings remain explicit."],"business":{"symbol":"bdx","status":"published","profile":{"basisHash":"b5242a5874e7d82ef4e12ac49b226e90cc0ef6242e5de27cc0bc07a674054c63","reviewedAt":"2026-10-20T12:29:18.239Z","metrics":[{"id":"series_89bedf644ff10811","label":"Medication Delivery Solutions · Operating Segments revenue","definition":"Reported quarterly Medication Delivery Solutions · Operating Segments revenue.","concept":"us-gaap:Revenues","unit":"iso4217:USD","cadence":"quarterly","dimensions":[{"axis":"srt:ConsolidationItemsAxis","member":"us-gaap:OperatingSegmentsMember"},{"axis":"bdx:OrganizationalUnitAxis","member":"bdx:MedicationDeliverySolutionsMember"},{"axis":"us-gaap:StatementBusinessSegmentsAxis","member":"bdx:MedicalEssentialsMember"}],"observations":[{"id":"650c802832b259c4debc9066864f9c70c487c481396106069129ce0522329889","sourceId":"operating-5e41315495c13eb1d6105ee9707e963deea0af86d3bdb860b86e50a5fbc26bc1","concept":"us-gaap:Revenues","contextRef":"c-150","start":"2025-01-01","end":"2025-03-31","dimensions":[{"axis":"srt:ConsolidationItemsAxis","member":"us-gaap:OperatingSegmentsMember"},{"axis":"bdx:OrganizationalUnitAxis","member":"bdx:MedicationDeliverySolutionsMember"},{"axis":"us-gaap:StatementBusinessSegmentsAxis","member":"bdx:MedicalEssentialsMember"}],"forecast":false,"scenario":false,"unit":"iso4217:USD","unitRef":"usd","value":1117000000,"decimal":"1117e6","observedText":"1,117","scale":6,"format":"ixt:num-dot-decimal","decimals":"-6","caption":"Medication Delivery Solutions","elementId":"f-624","conflict":false},{"id":"5346407489bb74396e66cf99d8be38d41305e7bd69e632b505bc8a4f81431829","sourceId":"operating-cb9430fedbdff7d9c58a2b407cc47c4055b0f69548fe76edcda621bcbcbe00de","concept":"us-gaap:Revenues","contextRef":"c-190","start":"2025-04-01","end":"2025-06-30","dimensions":[{"axis":"us-gaap:StatementBusinessSegmentsAxis","member":"bdx:MedicalEssentialsMember"},{"axis":"bdx:OrganizationalUnitAxis","member":"bdx:MedicationDeliverySolutionsMember"},{"axis":"srt:ConsolidationItemsAxis","member":"us-gaap:OperatingSegmentsMember"}],"forecast":false,"scenario":false,"unit":"iso4217:USD","unitRef":"usd","value":1132000000,"decimal":"1132e6","observedText":"1,132","scale":6,"format":"ixt:num-dot-decimal","decimals":"-6","caption":"Medication Delivery Solutions","elementId":"f-689","conflict":false},{"id":"f5827a2ccdc5ac97c7bafb1404ecab212de727d3b2fc9dff0774ba1f09ba0557","sourceId":"operating-5e41315495c13eb1d6105ee9707e963deea0af86d3bdb860b86e50a5fbc26bc1","concept":"us-gaap:Revenues","contextRef":"c-147","start":"2026-01-01","end":"2026-03-31","dimensions":[{"axis":"srt:ConsolidationItemsAxis","member":"us-gaap:OperatingSegmentsMember"},{"axis":"bdx:OrganizationalUnitAxis","member":"bdx:MedicationDeliverySolutionsMember"},{"axis":"us-gaap:StatementBusinessSegmentsAxis","member":"bdx:MedicalEssentialsMember"}],"forecast":false,"scenario":false,"unit":"iso4217:USD","unitRef":"usd","value":1163000000,"decimal":"1163e6","observedText":"1,163","scale":6,"format":"ixt:num-dot-decimal","decimals":"-6","caption":"Medication Delivery Solutions","elementId":"f-621","conflict":false},{"id":"06d96171dd8e040de8603d5820637a1c664307a67752b74f4e7d98987ee88be9","sourceId":"operating-cb9430fedbdff7d9c58a2b407cc47c4055b0f69548fe76edcda621bcbcbe00de","concept":"us-gaap:Revenues","contextRef":"c-187","start":"2026-04-01","end":"2026-06-30","dimensions":[{"axis":"us-gaap:StatementBusinessSegmentsAxis","member":"bdx:MedicalEssentialsMember"},{"axis":"bdx:OrganizationalUnitAxis","member":"bdx:MedicationDeliverySolutionsMember"},{"axis":"srt:ConsolidationItemsAxis","member":"us-gaap:OperatingSegmentsMember"}],"forecast":false,"scenario":false,"unit":"iso4217:USD","unitRef":"usd","value":1164000000,"decimal":"1164e6","observedText":"1,164","scale":6,"format":"ixt:num-dot-decimal","decimals":"-6","caption":"Medication Delivery Solutions","elementId":"f-686","conflict":false}]},{"id":"series_87999c22e78a4892","label":"Medication Management Solutions · Operating Segments revenue","definition":"Reported quarterly Medication Management Solutions · Operating Segments revenue.","concept":"us-gaap:Revenues","unit":"iso4217:USD","cadence":"quarterly","dimensions":[{"axis":"srt:ConsolidationItemsAxis","member":"us-gaap:OperatingSegmentsMember"},{"axis":"bdx:OrganizationalUnitAxis","member":"bdx:MedicationManagementSolutionsMember"},{"axis":"us-gaap:StatementBusinessSegmentsAxis","member":"bdx:ConnectedCareMember"}],"observations":[{"id":"ba11314c74f44dfd76b0bdf814a9bf7191e89479e2c7f7f5cc0b998684acd820","sourceId":"operating-5e41315495c13eb1d6105ee9707e963deea0af86d3bdb860b86e50a5fbc26bc1","concept":"us-gaap:Revenues","contextRef":"c-168","start":"2025-01-01","end":"2025-03-31","dimensions":[{"axis":"srt:ConsolidationItemsAxis","member":"us-gaap:OperatingSegmentsMember"},{"axis":"bdx:OrganizationalUnitAxis","member":"bdx:MedicationManagementSolutionsMember"},{"axis":"us-gaap:StatementBusinessSegmentsAxis","member":"bdx:ConnectedCareMember"}],"forecast":false,"scenario":false,"unit":"iso4217:USD","unitRef":"usd","value":811000000,"decimal":"811e6","observedText":"811","scale":6,"decimals":"-6","caption":"Medication Management Solutions","elementId":"f-642","conflict":false},{"id":"bfb6ad97cdb69bdc72a3f2bb4f1d2023db766bfc81ed48e8089c5737c54d2c4c","sourceId":"operating-cb9430fedbdff7d9c58a2b407cc47c4055b0f69548fe76edcda621bcbcbe00de","concept":"us-gaap:Revenues","contextRef":"c-208","start":"2025-04-01","end":"2025-06-30","dimensions":[{"axis":"us-gaap:StatementBusinessSegmentsAxis","member":"bdx:ConnectedCareMember"},{"axis":"bdx:OrganizationalUnitAxis","member":"bdx:MedicationManagementSolutionsMember"},{"axis":"srt:ConsolidationItemsAxis","member":"us-gaap:OperatingSegmentsMember"}],"forecast":false,"scenario":false,"unit":"iso4217:USD","unitRef":"usd","value":888000000,"decimal":"888e6","observedText":"888","scale":6,"decimals":"-6","caption":"Medication Management Solutions","elementId":"f-707","conflict":false},{"id":"9bc8c2f4c91653522e580f428024d4bbc94628c6c7f9128f32893da234be4439","sourceId":"operating-5e41315495c13eb1d6105ee9707e963deea0af86d3bdb860b86e50a5fbc26bc1","concept":"us-gaap:Revenues","contextRef":"c-165","start":"2026-01-01","end":"2026-03-31","dimensions":[{"axis":"srt:ConsolidationItemsAxis","member":"us-gaap:OperatingSegmentsMember"},{"axis":"bdx:OrganizationalUnitAxis","member":"bdx:MedicationManagementSolutionsMember"},{"axis":"us-gaap:StatementBusinessSegmentsAxis","member":"bdx:ConnectedCareMember"}],"forecast":false,"scenario":false,"unit":"iso4217:USD","unitRef":"usd","value":829000000,"decimal":"829e6","observedText":"829","scale":6,"decimals":"-6","caption":"Medication Management Solutions","elementId":"f-639","conflict":false},{"id":"487bd7b618a1bf5d4da966d122a10f92409364a81fb701d8f5d5aefa5b827e63","sourceId":"operating-cb9430fedbdff7d9c58a2b407cc47c4055b0f69548fe76edcda621bcbcbe00de","concept":"us-gaap:Revenues","contextRef":"c-205","start":"2026-04-01","end":"2026-06-30","dimensions":[{"axis":"us-gaap:StatementBusinessSegmentsAxis","member":"bdx:ConnectedCareMember"},{"axis":"bdx:OrganizationalUnitAxis","member":"bdx:MedicationManagementSolutionsMember"},{"axis":"srt:ConsolidationItemsAxis","member":"us-gaap:OperatingSegmentsMember"}],"forecast":false,"scenario":false,"unit":"iso4217:USD","unitRef":"usd","value":915000000,"decimal":"915e6","observedText":"915","scale":6,"decimals":"-6","caption":"Medication Management Solutions","elementId":"f-704","conflict":false}]},{"id":"series_9edd131413b4da4e","label":"BioPharma Systems · Operating Segments revenue","definition":"Reported quarterly BioPharma Systems · Operating Segments revenue.","concept":"us-gaap:Revenues","unit":"iso4217:USD","cadence":"quarterly","dimensions":[{"axis":"srt:ConsolidationItemsAxis","member":"us-gaap:OperatingSegmentsMember"},{"axis":"bdx:OrganizationalUnitAxis","member":"bdx:BioPharmaSystemsMember"},{"axis":"us-gaap:StatementBusinessSegmentsAxis","member":"bdx:BioPharmaSystemsMember"}],"observations":[{"id":"ee9cb1e87c87e8fd3845e350fd59a99764700154d70b2209d8892bc1c2f6b401","sourceId":"operating-5e41315495c13eb1d6105ee9707e963deea0af86d3bdb860b86e50a5fbc26bc1","concept":"us-gaap:Revenues","contextRef":"c-186","start":"2025-01-01","end":"2025-03-31","dimensions":[{"axis":"srt:ConsolidationItemsAxis","member":"us-gaap:OperatingSegmentsMember"},{"axis":"bdx:OrganizationalUnitAxis","member":"bdx:BioPharmaSystemsMember"},{"axis":"us-gaap:StatementBusinessSegmentsAxis","member":"bdx:BioPharmaSystemsMember"}],"forecast":false,"scenario":false,"unit":"iso4217:USD","unitRef":"usd","value":575000000,"decimal":"575e6","observedText":"575","scale":6,"decimals":"-6","caption":"BioPharma Systems","elementId":"f-660","conflict":false},{"id":"81cd3875c0e30b8318924a7679b8b7e155da950b84fd0b30b971896cf90c7af1","sourceId":"operating-cb9430fedbdff7d9c58a2b407cc47c4055b0f69548fe76edcda621bcbcbe00de","concept":"us-gaap:Revenues","contextRef":"c-226","start":"2025-04-01","end":"2025-06-30","dimensions":[{"axis":"us-gaap:StatementBusinessSegmentsAxis","member":"bdx:BioPharmaSystemsMember"},{"axis":"bdx:OrganizationalUnitAxis","member":"bdx:BioPharmaSystemsMember"},{"axis":"srt:ConsolidationItemsAxis","member":"us-gaap:OperatingSegmentsMember"}],"forecast":false,"scenario":false,"unit":"iso4217:USD","unitRef":"usd","value":629000000,"decimal":"629e6","observedText":"629","scale":6,"decimals":"-6","caption":"BioPharma Systems","elementId":"f-725","conflict":false},{"id":"e726112a74f696895ce5c6a0b6b6d59b87b97a1376ed76b2a09a46f0037241f6","sourceId":"operating-5e41315495c13eb1d6105ee9707e963deea0af86d3bdb860b86e50a5fbc26bc1","concept":"us-gaap:Revenues","contextRef":"c-183","start":"2026-01-01","end":"2026-03-31","dimensions":[{"axis":"srt:ConsolidationItemsAxis","member":"us-gaap:OperatingSegmentsMember"},{"axis":"bdx:OrganizationalUnitAxis","member":"bdx:BioPharmaSystemsMember"},{"axis":"us-gaap:StatementBusinessSegmentsAxis","member":"bdx:BioPharmaSystemsMember"}],"forecast":false,"scenario":false,"unit":"iso4217:USD","unitRef":"usd","value":590000000,"decimal":"590e6","observedText":"590","scale":6,"decimals":"-6","caption":"BioPharma Systems","elementId":"f-657","conflict":false},{"id":"552da9e5094e837e335bee7b96114a61d29796358ad2f331cc693c1683e8cb49","sourceId":"operating-cb9430fedbdff7d9c58a2b407cc47c4055b0f69548fe76edcda621bcbcbe00de","concept":"us-gaap:Revenues","contextRef":"c-223","start":"2026-04-01","end":"2026-06-30","dimensions":[{"axis":"us-gaap:StatementBusinessSegmentsAxis","member":"bdx:BioPharmaSystemsMember"},{"axis":"bdx:OrganizationalUnitAxis","member":"bdx:BioPharmaSystemsMember"},{"axis":"srt:ConsolidationItemsAxis","member":"us-gaap:OperatingSegmentsMember"}],"forecast":false,"scenario":false,"unit":"iso4217:USD","unitRef":"usd","value":670000000,"decimal":"670e6","observedText":"670","scale":6,"decimals":"-6","caption":"BioPharma Systems","elementId":"f-722","conflict":false}]}],"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/10795/000001079526000035/bdx-20260630.htm","accession":"0000010795-26-000035","filed":"2026-08-06","form":"10-Q","cik":"0000010795","sha256":"cb9430fedbdff7d9c58a2b407cc47c4055b0f69548fe76edcda621bcbcbe00de","retrievedAt":"2026-10-17T23:51:46.657Z","id":"operating-cb9430fedbdff7d9c58a2b407cc47c4055b0f69548fe76edcda621bcbcbe00de"},{"url":"https://www.sec.gov/Archives/edgar/data/10795/000001079526000026/bdx-20260331.htm","accession":"0000010795-26-000026","filed":"2026-05-07","form":"10-Q","cik":"0000010795","sha256":"5e41315495c13eb1d6105ee9707e963deea0af86d3bdb860b86e50a5fbc26bc1","retrievedAt":"2026-10-20T09:53:24.144Z","id":"operating-5e41315495c13eb1d6105ee9707e963deea0af86d3bdb860b86e50a5fbc26bc1"}],"limitations":["Selected disclosures measure business activity through sales; no operating-volume measures are supplied.","The selection is not a complete company breakdown."],"disclosures":{"reviewedAt":"2026-10-20T21:50:21.063Z","topics":[{"id":"topic_19de7502e3296e75","title":"BD Alaris™ Infusion System","kind":"operating_disclosure","evidence":[{"id":"q414","text":"As previously disclosed, on July 21, 2023, BD received 510(k) clearance from the FDA for its updated BD Alaris™ Infusion System, which enabled both remediation and a return to market for the BD Alaris™ Infusion System.","sourceId":"business-1","publishedAt":"2026-08-06"}]}],"sources":[{"id":"business-1","url":"https://www.sec.gov/Archives/edgar/data/10795/000001079526000035/bdx-20260630.htm","publishedAt":"2026-08-06","dateKind":"filed","sha256":"cb9430fedbdff7d9c58a2b407cc47c4055b0f69548fe76edcda621bcbcbe00de","citationPolicy":"numeric-blocks-2"}]}}},"source":"database","lastValidatedAt":"2026-11-06T22:00:21.819Z","lastCheckedAt":"2026-10-19T21:59:30.430Z"}